MedTrace Logo

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

NCT06985875 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2025-07-09

No results posted yet for this study

Summary

The aim of the trial is to compare the safety and efficacy of the moisturizing solution DROP 0.4% with the moisturizing solution AVIZOR EYE DROPS 0.2% PRESERVED in relieving the symptoms of dry eye over one month of use.

Conditions

  • Eye Dryness

Interventions

DEVICE

Multidose mosturizing solution DROP 0.4%

Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes

DEVICE

Multidose mosturizing solution Avizor Eye Drops 0.2% Preserved

Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes

Sponsors & Collaborators

  • Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

    collaborator OTHER

  • Avizor SA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06985875 on ClinicalTrials.gov